AtaiBeckley (ATAI) Other Accumulated Expenses (2021 - 2026)

AtaiBeckley's (ATAI) quarterly Other Accumulated Expenses came in at $179000.0 in Q1 2026, down 93.14% quarter-over-quarter from $2.6 million in Q4 2025.

AtaiBeckley (ATAI) Other Accumulated Expenses (2021 - 2026) Analysis & Trends

AtaiBeckley's Other Accumulated Expenses history runs 3 years deep, the most recent figure standing at $179000.0 for Q1 2026.

  • On a quarterly basis, Other Accumulated Expenses changed N/A year-over-year to $179000.0 in Q1 2026; TTM through Mar 2026 was $179000.0, a N/A change from a year earlier, with the FY2025 full-year figure at $2.6 million, up 386.03% from the prior year.
  • Other Accumulated Expenses fell to $179000.0 in Q1 2026 per ATAI's latest filing, from $2.6 million in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $1.1 million in Q3 2024 to a low of $8000.0 in Q3 2021.
  • A 5-year average of $605312.5 and a median of $556500.0 in 2024 frame the typical range for Other Accumulated Expenses.
  • Biggest YoY gain for Other Accumulated Expenses was 386.03% in 2025; the steepest drop was 386.03% in 2025.
  • Year by year, Other Accumulated Expenses stood at $537000.0 in 2024, then jumped by 386.03% to $2.6 million in 2025, then plunged by 93.14% to $179000.0 in 2026.
  • Per Business Quant, the three latest ATAI Other Accumulated Expenses figures stand at $179000.0 (Q1 2026), $2.6 million (Q4 2025), and $537000.0 (Q4 2024).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 69,146.49 Bn 69,146.20 Bn -
2 Nanobiotix 1,942.19 Bn 1,942.13 Bn -
3 Akari Therapeutics 1,132.35 Bn 1,132.35 Bn -
4 BeOne Medicines 475.42 Bn 470.63 Bn 1.35 Bn
5 Vertex Pharmaceuticals 123.32 Bn 116.08 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.80 Bn 61.04 Bn 3.31 Bn
7 Belite Bio 63.28 Bn 63.28 Bn -
8 Argenx Se 56.67 Bn 51.48 Bn 1.41 Bn
9 Revolution Medicines 38.15 Bn 38.15 Bn -
10 AtaiBeckley 1.56 Bn 1.56 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 179,000.00
Dec 31, 2025 2.61 Mn
Sep 30, 2025 487,000.00
Jun 30, 2025 421,000.00
Mar 31, 2025 576,000.00
Dec 31, 2024 537,000.00
Dec 31, 2024 537,000.00
Sep 30, 2024 1.11 Mn
Jun 30, 2024 1.04 Mn
Mar 31, 2024 877,000.00
Sep 30, 2023 463,000.00
Jun 30, 2023 890,000.00
Mar 31, 2023 795,000.00
Dec 31, 2022 12,000.00
Sep 30, 2022 958,000.00
Jun 30, 2022 1.11 Mn
Mar 31, 2022 227,000.00
Dec 31, 2021 163,000.00
Sep 30, 2021 8,000.00